Methylation status of RASSF1A in patients with chronic myeloid leukemia

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Kenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 181.5K citations

Life Sciences, Molecular Biology, Molecular Genetics +9

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

Kenichi Harada, Shinichi Toyooka, Anirban Maitra et al. · Oncogene · 2002 · 226 citations

Medicine, Genetics, Oncology +17

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis

Jian Yu, Min Ni, Jian Xu et al. · BMC Cancer · 2002 · 170 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Phase II study of low‐dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia

Yasuhiro Oki, Hagop M. Kantarjian, Vazganush Gharibyan et al. · Cancer · 2007 · 136 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Aberrant methylation of the negative regulators <i>RASSFIA</i>, <i>SHP‐1</i> and <i>SOCS‐1</i> in myelodysplastic syndromes and acute myeloid leukaemia

Muhammad Farid Johan, David Bowen, Marion E. Frew et al. · British Journal of Haematology · 2005 · 83 citations

Life Sciences, Genetics, Molecular Biology +17